Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Endocrinology | Family Medicine
 Disease Category: Pancreatic Cancer
Location: United States, NY

Trial Information

Pancreatic Cancer - Adults

A randomized, open-label phase II multicenter study evaluating the efficacy of oral Everolimus alone or in combination with Pasireotide LAR i.m. in advanced progressive pancreatic neuroendocrine tumors (PNET) –The COOPERATE-2 study People with advanced pancreatic neuroendocrine tumor are asked to participate in a research study being conducted by Montefiore Medical Center.

Patient Inclusion Criteria:
You may be eligible to participate in this study if you:

  • Are at least 18 years old
  • Have been diagnosed with advanced pancreatic neuroendocrine tumor.

Patient Exclusion Criteria:
You may not participate in this study if you:

  • Are a woman who is pregnant or breastfeeding
  • Are a man whose partner is pregnant
  • Have a history of syncope (episodes of fainting)
  • Have a family history of sudden death
  • Have any severe and/or uncontrolled medical conditions

Yue-Jin Wen, Study Coordinator
Biomedical Research Alliance of New York
Montefiore Medical Center
1521 Jarret Place
Bronx, NY 10461
Phone: 718-862-8847
Fax: 718-862-8854
Email: ywen@montefiore.org

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.